Sun Pharma Advanced Research Company Ltd Board of Directors
Board of Directors at Sun Pharma Advanced Research Company Ltd
Bhavna Doshi
Independent Director
Dilip Shanghvi
Chairman (Non-Executive)
Ferzaan Engineer
Independent Director
Kajal Damania.
Company Sec. & Compli. Officer
Robert Spiegel
Independent Director
Key Highlights
- Dilip S Shanghvi joins the board as Chairman & Non Executive Dir., in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Vidhi Shanghvi joins the board as Non-Exec & Non-Independent Dir, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Robert Spiegel joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Venkateswarlu Jasti joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Rekha Warriar joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Sun Pharma Advanced Research Company Ltd
NSE: SPARC
Share Price
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 09 Oct 2026 | 185.35 |
| 08 Oct 2026 | 187.9 |
| 07 Oct 2026 | 197.6 |
| 06 Oct 2026 | 196.75 |
| 05 Oct 2026 | 190.7 |
| 01 Oct 2026 | 194.25 |
| 30 Sep 2026 | 197.2 |
| 29 Sep 2026 | 208.75 |
| 28 Sep 2026 | 202.75 |
| 25 Sep 2026 | 209.2 |
Company Fundamentals for Sun Pharma Advanced Research Company Ltd
Market Cap
6,015 Cr
EPS
49.2
P/E Ratio (TTM)
3.8
P/B Ratio (TTM)
4.5
Day’s High
192.4
Day’s Low
184.4
DTE
0.4
ROE
116.0
52 Week High
289.0
52 Week Low
108.2
ROCE
80.9
Market Price of Sun Pharma Advanced Research Company Ltd
1M
1Y
3Y
5Y
Monitoring Sun Pharma Advanced Research Company Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Sun Pharma Advanced Research Company Ltd News Hub
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 95.90 crore in the June 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 95.90 crore in the quarter ended Jun
Read more
05 Aug 24
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 107.33 crore in the September 2024 quarter
Net Loss of Sun Pharma Advanced Research Company reported to Rs 107.33 crore in the quarter ended Se
Read more
04 Nov 24
Sun Pharma Advanced Research Company to convene board meeting
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on
Read more
25 Oct 24
SPARC drops as Q2 net loss widens to Rs 107 crore
Net sales declined 39.29% year on year (YoY) to 12.86 crore in the quarter ended 30 September 2024.
Read more
04 Nov 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
FAQs for Board of Directors of Sun Pharma Advanced Research Company Ltd
How are members of Sun Pharma Advanced Research Company Ltd Board of Directors selected?
Members of the Sun Pharma Advanced Research Company Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Sun Pharma Advanced Research Company Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.
Can shareholders interact with the Sun Pharma Advanced Research Company Ltd Board of Directors?
Shareholders can interact with the Sun Pharma Advanced Research Company Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.
How often does the Sun Pharma Advanced Research Company Ltd Board of Directors meet?
The Sun Pharma Advanced Research Company Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.
What are the responsibilities of the Sun Pharma Advanced Research Company Ltd Board of Directors?
The Sun Pharma Advanced Research Company Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.
Who are the current members of the Board of Directors at Sun Pharma Advanced Research Company Ltd?
The current Board of Directors at Sun Pharma Advanced Research Company Ltd includes Dilip S Shanghvi( Chairman & Non Executive Dir.) ,Vidhi Shanghvi( Non-Exec & Non-Independent Dir) ,Robert Spiegel( Independent Non Exe. Director) ,Venkateswarlu Jasti( Independent Non Exe. Director) ,Rekha Warriar( Independent Non Exe. Director) . The full list can be found on Sun Pharma Advanced Research Company Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
